Jade Biosciences

Acquired

On a mission to transform the future of autoimmune care.

Public · Waltham, United States · Founded 2024 · $380.0M raised

Employees
11–50
Founded
2024
Business Model
B2B
Total Funding
$380.0M
Last Round
$300.0M Corporate RoundApr 2025
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Jade Biosciences is a clinical-stage biotechnology company founded in 2024 and headquartered in Waltham, Massachusetts, focused on developing best-in-class antibody-based therapies for patients with autoimmune diseases. Its lead program, JADE101, targets inflammation and immunology indications with high unmet need. The company launched with $80M in financing led by Fairmount and Venrock Healthcare Capital Partners.

Summary

Jade Biosciences is a Biotech company based in Waltham, United States, founded in 2024. It has raised $380.0M in total across 2 rounds, most recently a $300.0M Corporate Round in Apr 2025. Investors include Fairmount and Venrock.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundApr 2025
$300.0M

Sign up to see all 3 events

Funding: Venture Round through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Jade Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/jade-biosciences"><img src="https://indexed.vc/api/badge/company/jade-biosciences" alt="Jade Biosciences on Indexed.vc" width="260" height="76" /></a>